{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:20:38Z","timestamp":1761744038129,"version":"3.40.3"},"publisher-location":"Cham","reference-count":93,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783319121130"},{"type":"electronic","value":"9783319121147"}],"license":[{"start":{"date-parts":[[2014,12,4]],"date-time":"2014-12-04T00:00:00Z","timestamp":1417651200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2014,12,4]],"date-time":"2014-12-04T00:00:00Z","timestamp":1417651200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015]]},"DOI":"10.1007\/978-3-319-12114-7_3","type":"book-chapter","created":{"date-parts":[[2014,12,3]],"date-time":"2014-12-03T11:32:05Z","timestamp":1417606325000},"page":"61-81","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["The Many Faces of Prolactin in Breast Cancer"],"prefix":"10.1007","author":[{"given":"Wen Y","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,12,4]]},"reference":[{"key":"3_CR1","first-page":"31","volume-title":"Biology of female cancers","author":"P Forrest","year":"1997","unstructured":"Forrest P (1997) Introduction to breast cancer. In: Langdon SP, Miller WR, Berchuck A (eds) Biology of female cancers. CRC Press, LLC, pp\u00a031\u201342"},{"key":"3_CR2","unstructured":"(2008) The MD Anderson Cancer Care Series: breast cancer, 2nd edn. In: KK Hunt, GL Robb, EA Strom, NT Ueno (eds) Springer Science Business Media LLC, New York, 561\u00a0p. Softcover. ISBN 978-0-387-34950-3"},{"key":"3_CR3","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1210\/edrv-12-3-235","volume":"12","author":"PA Kelly","year":"1991","unstructured":"Kelly PA, Djiane J, Postel-Vinay MC, Edery M (1991) The prolactin\/growth hormone receptor family. Endocri Rev 12:235\u2013251","journal-title":"Endocri Rev"},{"key":"3_CR4","doi-asserted-by":"publisher","first-page":"6926","DOI":"10.1093\/emboj\/16.23.6926","volume":"16","author":"ND Horseman","year":"1997","unstructured":"Horseman ND, Zhao W, Montecino-Rodriguez E, Tanaka M, Nakashima K, Engle SJ, Smith F (1997) Defective mammopoiesis, but normal hematopoiesis, in mice with a targeted disruption of the prolactin gene. EMBO J 16:6926\u20136935","journal-title":"EMBO J"},{"key":"3_CR5","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1101\/gad.11.2.167","volume":"15","author":"CJ Ormandy","year":"1997","unstructured":"Ormandy CJ, Camus A, Barra J, Damotte D, Lucas B, Buteau H, Edery M, Brousse N, Babinet C, Binart N, Kelly PA (1997) Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse. Genes Dev 15:167\u2013178","journal-title":"Genes Dev"},{"issue":"12","key":"3_CR6","first-page":"2591","volume":"55","author":"E Ginsburg","year":"1995","unstructured":"Ginsburg E, Vonderhaar BK (1995) Prolactin synthesis and secretion by human breast cancer cells. Cancer Res 55(12):2591\u20132595","journal-title":"Cancer Res"},{"issue":"1","key":"3_CR7","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s10911-008-9062-z","volume":"13","author":"KU Wagner","year":"2008","unstructured":"Wagner KU, Rui H (2008) Jak2\/Stat5 signaling in mammogenesis, breast cancer initiation and progression. J Mammary Gland Biol Neoplasia 13(1):93\u2013103. Review","journal-title":"J Mammary Gland Biol Neoplasia"},{"issue":"2","key":"3_CR8","doi-asserted-by":"publisher","first-page":"R91","DOI":"10.1677\/ERC-09-0253","volume":"17","author":"EW LaPensee","year":"2010","unstructured":"LaPensee EW, Ben-Jonathan N (2010) Novel roles of prolactin and estrogens in breast cancer: resistance to chemotherapy. Endocr Relat Cancer 17(2):R91\u2013107 (Review)","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"3_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/er.2001-0036","volume":"24","author":"CV Clevenger","year":"2003","unstructured":"Clevenger CV, Furth PA, Hankinson SE, Schuler LA (2003) The role of prolactin in mammary carcinoma. Endocr Rev 24(1):1\u201327 (Review)","journal-title":"Endocr Rev"},{"key":"3_CR10","first-page":"431","volume":"1","author":"M Cecim","year":"1994","unstructured":"Cecim M, Bartke A, Yun JS, Wagner TE (1994) Expression of human, but not bovine, growth hormone genes promotes development of mammary tumors in transgenic mice. Transgenics 1:431\u2013437","journal-title":"Transgenics"},{"key":"3_CR11","doi-asserted-by":"publisher","first-page":"2744","DOI":"10.1172\/JCI119820","volume":"100","author":"H Wennbo","year":"1997","unstructured":"Wennbo H, Gebre-Medhin M, Gritli-Linde A, Ohlsson C, Isaksson OG, Tornell J (1997) Activation of the prolactin receptor but not the growth hormone receptor is important for induction of mammary tumors in transgenic mice. J Clin Invest 100:2744\u20132751","journal-title":"J Clin Invest"},{"issue":"1","key":"3_CR12","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s10911-008-9073-9","volume":"13","author":"LM Arendt","year":"2008","unstructured":"Arendt LM, Schuler LA (2008) Transgenic models to study actions of prolactin in mammary neoplasia. J Mammary Gland Biol Neoplasia 13(1):29\u201340 (Review)","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"3_CR13","first-page":"2317","volume":"42","author":"DM Purnell","year":"1982","unstructured":"Purnell DM, Hillman EA, Heatfield BM, Trump BF (1982) Immunoreactive prolactin in epithelial cells of normal and cancerous human breast and prostate detected by the unlabeled antibody peroxidase-antiperoxidase method. Cancer Res 42:2317\u20132324","journal-title":"Cancer Res"},{"key":"3_CR14","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1210\/endo-117-5-2040","volume":"117","author":"A Manni","year":"1985","unstructured":"Manni A, Pontari M, Wright C (1985) Autocrine stimulation by prolactin of hormone-responsive breast cancer growth in culture. Endocrinology 117:2024\u20132043","journal-title":"Endocrinology"},{"key":"3_CR15","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1210\/endo.136.8.7628401","volume":"136","author":"J Mershon","year":"1995","unstructured":"Mershon J, Sall W, Mitchner N, Ben-Jonathan N (1995) Prolactin is a local growth factor in rat mammary tumors. Endocrinology 136:3619\u20133623","journal-title":"Endocrinology"},{"key":"3_CR16","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1002\/1097-0142(19910915)68:6<1401::AID-CNCR2820680637>3.0.CO;2-K","volume":"68","author":"RR Love","year":"1991","unstructured":"Love RR, Rose DR, Surawicz TS, Newcomb PA (1991) Prolactin and growth hormone levels in premenopausal women with breast cancer and healthy women with strong family history of breast cancer. Cancer 68:1401\u20131405","journal-title":"Cancer"},{"key":"3_CR17","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/BF01806753","volume":"1","author":"JP Peyrat","year":"1981","unstructured":"Peyrat JP, DeWailly D, Djiane J, Kelly PA, Vandewalle B, Bonneterre J, LeFebvre. J (1981) Total prolactin binding sites in human breast cancer biopsies. Breast Cancer Res Treat 1:369\u2013373","journal-title":"Breast Cancer Res Treat"},{"key":"3_CR18","doi-asserted-by":"crossref","first-page":"5555","DOI":"10.1210\/endo.138.12.5605","volume":"138","author":"C Reynolds","year":"1997","unstructured":"Reynolds C, Montone KT, Powell CM, Tomaszewski JE, Clevenger C (1997) Expression of prolactin and its receptor in human breast carcinoma. Endocrinology 138:5555\u20135560","journal-title":"Endocrinology"},{"issue":"2","key":"3_CR19","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1210\/jcem.83.2.4564","volume":"83","author":"P Touraine","year":"1998","unstructured":"Touraine P, Martini JF, Zafrani B, Durand JC, Labaille F, Malet C, Nicolas A, Trivin C, Postel-Vinay MC, Kuttenn F, Kelly PA (1998) Increased expression of prolactin receptor gene assessed by quantitative polymerase chain reaction in human breast tumors versus normal breast tissues. J Clin Endocrinol Metab 83(2):667\u2013674","journal-title":"J Clin Endocrinol Metab"},{"key":"3_CR20","doi-asserted-by":"publisher","first-page":"5061","DOI":"10.1073\/pnas.87.13.5061","volume":"87","author":"WY Chen","year":"1990","unstructured":"Chen WY, Wight DC, Wagner TE, Kopchick JJ (1990) Expression of a mutated bovine growth hormone gene suppresses growth of transgenic mice. Proc Natl Acad Sci USA 87:5061\u20135065","journal-title":"Proc Natl Acad Sci USA"},{"key":"3_CR21","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1210\/endo-129-3-1402","volume":"129","author":"WY Chen","year":"1991","unstructured":"Chen WY, White ME, Wagner TE, Kopchick JJ (1991) Functional antagonism between endogenous mouse growth hormone (GH) and a GH analog results in transgenic dwarf mice. Endocrinology 129:1402\u20131408","journal-title":"Endocrinology"},{"key":"3_CR22","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1210\/mend-5-12-1845","volume":"5","author":"WY Chen","year":"1991","unstructured":"Chen WY, Wight DC, Mehta BV, Wagner TE, Kopchick JJ (1991) Glycine 119 of bovine growth hormone is critical for growth promoting activity. Mol Endocrinol 5:1845\u20131852","journal-title":"Mol Endocrinol"},{"key":"3_CR23","doi-asserted-by":"crossref","first-page":"15892","DOI":"10.1016\/S0021-9258(17)40764-2","volume":"269","author":"WY Chen","year":"1994","unstructured":"Chen WY, Chen NY, Yun J, Wagner TE, Kopchick JJ (1994) In vitro and in vivo studies of antagonists effects of human growth hormone analogs. J Biol Chem 269:15892\u201315897","journal-title":"J Biol Chem"},{"key":"3_CR24","first-page":"292","volume":"9","author":"WY Chen","year":"1995","unstructured":"Chen WY, Chen NY, Yun J, Wight DC, Wang XZ, Wagner TE, Kopchick JJ (1995) Amino acid residues in the third alpha-helix of growth hormone involved in growth promoting activity. Mol Endocrinol 9:292\u2013302","journal-title":"Mol Endocrinol"},{"key":"3_CR25","first-page":"2284","volume":"130","author":"S Okada","year":"1992","unstructured":"Okada S, Chen WY, Wiehl P, Kelder B, Goodman HM, Guller S, Sonenberg M, Kopchick JJ (1992) A growth hormone (GH) analog can antagonize the ability of native GH to promote differentiation of 3T3-F442\u00a0A preadipocytes and to stimulate insulin-like and lipolytic activities in primary rat adipocytes. Endocrinology 130:2284\u20132290","journal-title":"Endocrinology"},{"key":"3_CR26","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1126\/science.256.5064.1677","volume":"256","author":"G Fuh","year":"1992","unstructured":"Fuh G, Cunningham BC, Fukunaga R, Nagata S, Goeddel DV, Wells JA (1992) Rational design of potent antagonists to the human growth hormone receptor. Science 256:1677\u20131680","journal-title":"Science"},{"key":"3_CR27","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1126\/science.1549776","volume":"255","author":"A DeVos","year":"1992","unstructured":"DeVos A, Ultsch M, Kosslakoff AA (1992) Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science 255:306\u2013312","journal-title":"Science"},{"key":"3_CR28","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1126\/science.2270485","volume":"250","author":"BC Cunningham","year":"1990","unstructured":"Cunningham BC, Bass S, Fuh G, Wells JA (1990) Zinc mediation of the binding of human growth hormone to the human prolactin receptor. Science 250:1709\u20131712","journal-title":"Science"},{"key":"3_CR29","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1210\/mend-5-12-1880","volume":"5","author":"DN Luck","year":"1991","unstructured":"Luck DN, Huyer M, Gout PW, Beer CT, Smith M (1991) Single amino acid substitutions in recombinant bovine prolactin that markedly reduce its mitogenic activity in NB2 cell cultures. Mol Endocrinol 5:1880\u20131886","journal-title":"Mol Endocrinol"},{"issue":"2","key":"3_CR30","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1210\/me.2012-1297","volume":"27","author":"J Xu","year":"2013","unstructured":"Xu J, Sun D, Jiang J, Deng L, Zhang Y, Yu H, Bahl D, Langenheim JF, Chen WY, Fuchs SY, Frank SJ (2013) The role of prolactin receptor in GH signaling in breast cancer cells. Mol Endocrinol 27(2):266\u2013279","journal-title":"Mol Endocrinol"},{"issue":"4","key":"3_CR31","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1210\/me.2010-0255","volume":"25","author":"J Xu","year":"2011","unstructured":"Xu J, Zhang Y, Berry PA, Jiang J, Lobie PE, Langenheim JF, Chen WY, Frank SJ (2011) Growth hormone signaling in human T47D breast cancer cells: potential role for a growth hormone receptor-prolactin receptor complex. Mol Endocrinol 25(4):597\u2013610","journal-title":"Mol Endocrinol"},{"issue":"4","key":"3_CR32","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1210\/me.2007-0424","volume":"22","author":"N Yang","year":"2008","unstructured":"Yang N, Langenheim JF, Wang X, Jiang J, Chen WY, Frank SJ (2008) Activation of growth hormone receptors by growth hormone and growth hormone antagonist dimers: insights into receptor triggering. Mol Endocrinol 22(4):978\u2013988","journal-title":"Mol Endocrinol"},{"issue":"5","key":"3_CR33","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.tem.2009.03.001","volume":"20","author":"CV Clevenger","year":"2009","unstructured":"Clevenger CV, Gadd SL, Zheng J (2009) New mechanisms for PRLr action in breast cancer. Trends Endocrinol Metab 20(5):223\u2013229 (Review)","journal-title":"Trends Endocrinol Metab"},{"key":"3_CR34","doi-asserted-by":"crossref","first-page":"32598","DOI":"10.1016\/S0021-9258(18)31676-4","volume":"269","author":"V Goffin","year":"1994","unstructured":"Goffin V, Struman I, Mainfroid V, Kinet S, Martial JA (1994) Evidence for a second receptor binding site on human prolactin. J Biol Chem 269:32598\u201332606","journal-title":"J Biol Chem"},{"issue":"37","key":"3_CR35","doi-asserted-by":"publisher","first-page":"26033","DOI":"10.1074\/jbc.274.37.26033","volume":"274","author":"S Kinet","year":"1999","unstructured":"Kinet S, Bernichtein S, Kelly PA, Martial JA, Goffin V (1999) Biological properties of human prolactin analogs depend not only on global hormone affinity, but also on the relative affinities of both receptor binding sites. J Biol Chem 274(37):26033\u201326043","journal-title":"J Biol Chem"},{"issue":"11","key":"3_CR36","first-page":"3583","volume":"5","author":"WY Chen","year":"1999","unstructured":"Chen WY, Ramamoorthy P, Chen N, Sticca R, Wagner TE (1999) A human prolactin antagonist, hPRL-G129R, inhibits breast cancer cell proliferation through induction of apoptosis. Clin Cancer Res 5(11):3583\u20133593","journal-title":"Clin Cancer Res"},{"issue":"3","key":"3_CR37","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1210\/er.2004-0016","volume":"26","author":"V Goffin","year":"2005","unstructured":"Goffin V, Bernichtein S, Touraine P, Kelly PA (2005) Development and potential clinical uses of human prolactin receptor antagonists. Endocr Rev 26(3):400\u2013422","journal-title":"Endocr Rev"},{"issue":"1","key":"3_CR38","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1677\/joe.0.171R001","volume":"171","author":"SK Peirce","year":"2001","unstructured":"Peirce SK, Chen WY (2001) Quantification of prolactin receptor mRNA in multiple human tissues and cancer cell lines by real time RT-PCR. J Endocrinol 171(1):R1\u2013R4","journal-title":"J Endocrinol"},{"issue":"1","key":"3_CR39","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s10549-013-2731-7","volume":"142","author":"LM Nitze","year":"2013","unstructured":"Nitze LM, Galsgaard ED, Din N, Lund VL, Rasmussen BB, Berchtold MW, Christensen L, Panina S (2013) Reevaluation of the proposed autocrine proliferative function of prolactin in breast cancer. Breast Cancer Res Treat 142(1):31\u201344","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"3_CR40","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646\u2013674. Review","journal-title":"Cell"},{"issue":"6","key":"3_CR41","first-page":"1179","volume":"17","author":"L Cataldo","year":"2000","unstructured":"Cataldo L, Chen NY, Yuan Q, Li W, Ramamoorthy P, Wagner TE, Sticca RP, Chen WY (2000) Inhibition of oncogene STAT3 phosphorylation by a prolactin antagonist, hPRL-G129R, in T-47D human breast cancer cells. Int J Oncol 17(6):1179\u20131185","journal-title":"Int J Oncol"},{"issue":"1","key":"3_CR42","first-page":"25","volume":"18","author":"P Ramamoorthy","year":"2001","unstructured":"Ramamoorthy P, Sticca R, Wagner TE, Chen WY (2001) In vitro studies of a prolactin antagonist, hPRL-G129R in human breast cancer cells. Int J Oncol 18(1):25\u201332","journal-title":"Int J Oncol"},{"issue":"5","key":"3_CR43","first-page":"1381","volume":"27","author":"S Tomblyn","year":"2005","unstructured":"Tomblyn S, Langenheim JF, Jacquemart IC, Holle E, Chen WY (2005) The role of human prolactin and its antagonist, G129R, in mammary gland development and DMBA-initiated tumorigenesis in transgenic mice. Int J Oncol 27(5):1381\u20131389","journal-title":"Int J Oncol"},{"issue":"2","key":"3_CR44","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s10549-007-9789-z","volume":"111","author":"ML Scotti","year":"2008","unstructured":"Scotti ML, Langenheim JF, Tomblyn S, Springs AE, Chen WY (2008) Additive effects of a prolactin receptor antagonist, G129R, and herceptin on inhibition of HER2-overexpressing breast cancer cells. Breast Cancer Res Treat 111(2):241\u2013250","journal-title":"Breast Cancer Res Treat"},{"key":"3_CR45","doi-asserted-by":"publisher","first-page":"480","DOI":"10.3389\/fphys.2012.00480","volume":"3","author":"B Stransky","year":"2013","unstructured":"Stransky B, de Souza SJ (2013) Modeling tumor evolutionary dynamics. Front Physiol 3:480","journal-title":"Front Physiol"},{"issue":"38","key":"3_CR46","doi-asserted-by":"publisher","first-page":"14533","DOI":"10.1073\/pnas.0800685105","volume":"105","author":"RL Bogorad","year":"2008","unstructured":"Bogorad RL, Courtillot C, Mestayer C, Bernichtein S, Harutyunyan L, Jomain JB, Bachelot A, Kuttenn F, Kelly PA, Goffin V, Touraine P (2008) Benign breast diseases study group. Identification of a gain-of-function mutation of the prolactin receptor in women with benign breast tumors. Proc Natl Acad Sci U S A 105(38):14533\u201314538","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"13","key":"3_CR47","first-page":"3598","volume":"63","author":"MT Beck","year":"2003","unstructured":"Beck MT, Chen NY, Franek KJ, Chen WY (2003) Prolactin antagonist-endostatin fusion protein as a targeted dual-functional therapeutic agent for breast cancer. Cancer Res 63(13):3598\u20133604","journal-title":"Cancer Res"},{"issue":"4","key":"3_CR48","first-page":"1196","volume":"8","author":"G Zhang","year":"2002","unstructured":"Zhang G, Li W, Holle L, Chen N, Chen WY (2002) A novel design of targeted endocrine and cytokine therapy for breast cancer. Clin Cancer Res 8(4):1196\u20131205","journal-title":"Clin Cancer Res"},{"issue":"3","key":"3_CR49","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s10549-004-4816-9","volume":"90","author":"JF Langenheim","year":"2005","unstructured":"Langenheim JF, Chen WY (2005) Development of a prolactin receptor-targeting fusion toxin using a prolactin antagonist and a recombinant form of Pseudomonas exotoxin A. Breast Cancer Res Treat 90(3):281\u2013293","journal-title":"Breast Cancer Res Treat"},{"key":"3_CR50","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S0065-230X(08)60058-5","volume":"19","author":"J Folkman","year":"1974","unstructured":"Folkman J (1974) Tumor angiogenesis. Adv Cancer Res 19:331\u2013358 (Review)","journal-title":"Adv Cancer Res"},{"issue":"4","key":"3_CR51","first-page":"1139","volume":"34","author":"S Tomblyn","year":"2009","unstructured":"Tomblyn S, Springs AE, Langenheim JF, Chen WY (2009) Combination therapy using three novel prolactin receptor antagonist-based fusion proteins effectively inhibits tumor recurrence and metastasis in HER2\/neu transgenic mice. Int J Oncol 34(4):1139\u20131146","journal-title":"Int J Oncol"},{"issue":"3","key":"3_CR52","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1677\/ERC-09-0326","volume":"17","author":"LM Rasmussen","year":"2010","unstructured":"Rasmussen LM, Frederiksen KS, Din N, Galsgaard E, Christensen L, Berchtold MW, Panina S (2010) Prolactin and oestrogen synergistically regulate gene expression and proliferation of breast cancer cells. Endocr Relat Cancer 17(3):809\u2013822","journal-title":"Endocr Relat Cancer"},{"issue":"2","key":"3_CR53","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s10549-007-9789-z","volume":"111","author":"ML Scotti","year":"2008","unstructured":"Scotti ML, Langenheim JF, Tomblyn S, Springs AE, Chen WY (2008) Additive effects of a prolactin receptor antagonist, G129R, and herceptin on inhibition of HER2-overexpressing breast cancer cells. Breast Cancer Res Treat 111(2):241\u2013250","journal-title":"Breast Cancer Res Treat"},{"issue":"43","key":"3_CR54","doi-asserted-by":"publisher","first-page":"33937","DOI":"10.1074\/jbc.M000743200","volume":"275","author":"T Yamauchi","year":"2000","unstructured":"Yamauchi T, Yamauchi N, Ueki K, Sugiyama T, Waki H, Miki H, Tobe K, Matsuda S, Tsushima T, Yamamoto T, Fujita T, Taketani Y, Fukayama M, Kimura S, Yazaki Y, Nagai R, Kadowaki T (2000) Constitutive tyrosine phosphorylation of ErbB-2 via Jak2 by autocrine secretion of prolactin in human breast cancer. J Biol Chem 275(43):33937\u201333944","journal-title":"J Biol Chem"},{"issue":"1","key":"3_CR55","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s10549-012-1954-3","volume":"134","author":"C Xu","year":"2012","unstructured":"Xu C, Langenheim JF, Chen WY (2012) Stromal-epithelial interactions modulate cross-talk between prolactin receptor and HER2\/Neu in breast cancer. Breast Cancer Res Treat 134(1):157\u2013169","journal-title":"Breast Cancer Res Treat"},{"issue":"14","key":"3_CR56","first-page":"187","volume":"7","author":"Y Wen","year":"2014","unstructured":"Wen Y, Zand B, Ozpolat B, Szczepanski MJ, Lu C, Yuca E, Carroll AR, Alpay N, Bartholomeusz C, Tekedereli I, Kang Y, Rupaimoole R, Pecot CV, Dalton HJ, Hernandez A, Lokshin A, Lutgendorf SK, Liu J, Hittelman WN, Chen WY, Lopez-Berestein G, Szajnik M, Ueno NT, Coleman RL, Sood AK (2014) Antagonism of tumoral prolactin receptor promotes autophagy-related cell death. Cell Rep 7(14):187\u2013189","journal-title":"Cell Rep"},{"key":"3_CR57","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.ctrv.2008.01.007","volume":"34","author":"HM Coley","year":"2008","unstructured":"Coley HM (2008) Mechanisms and strategies to overcome chemotherapy resistance in metastatic breast cancer. Cancer Treat Rev 34:378\u2013390","journal-title":"Cancer Treat Rev"},{"key":"3_CR58","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1126\/science.1171837","volume":"324","author":"JM Rosen","year":"2009","unstructured":"Rosen JM, Jordan CT (2009) The increasing complexity of the cancer stem cell paradigm. Science 324:1670\u20131673","journal-title":"Science"},{"key":"3_CR59","doi-asserted-by":"publisher","first-page":"50","DOI":"10.2174\/157488809787169110","volume":"4","author":"H Nakshatri","year":"2009","unstructured":"Nakshatri H, Srour EF, Badve S (2009) Breast cancer stem cells and intrinsic subtypes: controversies rage on. Curr Stem Cell Res Ther 4:50\u201360","journal-title":"Curr Stem Cell Res Ther"},{"issue":"3","key":"3_CR60","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1083\/jcb.201202014","volume":"198","author":"I Baccelli","year":"2012","unstructured":"Baccelli I, Trumpp A (2012) The evolving concept of cancer and metastasis stem cells. J Cell Biol 198(3):281\u2013293","journal-title":"J Cell Biol"},{"issue":"7","key":"3_CR61","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/nm0797-730","volume":"3","author":"D Bonnet","year":"1997","unstructured":"Bonnet D, Dick JE (1997) Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3(7):730\u2013737","journal-title":"Nat Med"},{"issue":"3","key":"3_CR62","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1002\/stem.1035","volume":"30","author":"HR Siddique","year":"2012","unstructured":"Siddique HR, Saleem M (2012) Role of BMI1, a stem cell factor, in cancer recurrence and chemoresistance: preclinical and clinical evidences. Stem Cells 30(3):372\u2013378","journal-title":"Stem Cells"},{"issue":"1","key":"3_CR63","first-page":"25","volume":"25","author":"G Federici","year":"2011","unstructured":"Federici G, Espina V, Liotta L, Edmiston KH (2011) Breast cancer stem cells: a new target for therapy. Oncology (Williston Park) 25(1):25\u201328 (Review)","journal-title":"Oncology (Williston Park)"},{"issue":"2","key":"3_CR64","doi-asserted-by":"publisher","first-page":"196","DOI":"10.2174\/138920111794295657","volume":"12","author":"A Nicolini","year":"2011","unstructured":"Nicolini A, Ferrari P, Fini M, Borsari V, Fallahi P, Antonelli A, Berti P, Carpi A, Miccoli P (2011) Stem cells: their role in breast cancer development and resistance to treatment. Curr Pharm Biotechnol 12(2):196\u2013205 (Review)","journal-title":"Curr Pharm Biotechnol"},{"issue":"24","key":"3_CR65","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1093\/jnci\/djr451","volume":"103","author":"S Azzi","year":"2011","unstructured":"Azzi S, Bruno S, Giron-Michel J, Clay D, Devocelle A, Croce M, Ferrini S, Chouaib S, Vazquez A, Charpentier B, Camussi G, Azzarone B, Eid P (2011) Differentiation therapy: targeting human renal cancer stem cells with interleukin 15. J Natl Cancer Inst 103(24):1884\u20131898","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"3_CR66","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/S1534-5807(01)00064-8","volume":"1","author":"L Hennighausen","year":"2001","unstructured":"Hennighausen L, Robinson GW (2001) Signaling pathways in mammary gland development. Dev Cell 1(4):467\u2013475","journal-title":"Dev Cell"},{"issue":"6","key":"3_CR67","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/bcr1331","volume":"7","author":"L Hinck","year":"2005","unstructured":"Hinck L, Silberstein GB (2005) Key stages in mammary gland development: the mammary end bud as a motile organ. Breast Cancer Res 7(6):245\u2013251","journal-title":"Breast Cancer Res"},{"key":"3_CR68","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.1073\/pnas.0530291100","volume":"100","author":"M Al-Hajj","year":"2003","unstructured":"Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF (2003) Prospective identification of tumori- genic breast cancer cells. Proc Natl Acad Sci U S A 100:3983\u20133988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3_CR69","doi-asserted-by":"publisher","first-page":"5506","DOI":"10.1158\/0008-5472.CAN-05-0626","volume":"65","author":"D Ponti","year":"2005","unstructured":"Ponti D, Costa A, Zaffaroni N, Pratesi G, Petrangolini G, Coradini D, Pilotti S, Pierotti MA, Daidone MG (2005) Isolation and in vitro propagation of tumorigenic breast cancer cells with stem\/pro- genitor cell properties. Cancer Res 65:5506\u20135511","journal-title":"Cancer Res"},{"issue":"4","key":"3_CR70","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.surg.2006.12.015","volume":"141","author":"EH1 Huang","year":"2007","unstructured":"Huang EH1, Heidt DG, Li CW, Simeone DM (2007) Cancer stem cells: a new paradigm for understanding tumor progression and therapeutic resistance. Surgery 141(4):415\u2013419","journal-title":"Surgery"},{"issue":"5","key":"3_CR71","doi-asserted-by":"publisher","first-page":"661","DOI":"10.2217\/bmm.11.57","volume":"5","author":"Y G\u00f6kmen-Polar","year":"2011","unstructured":"G\u00f6kmen-Polar Y, Nakshatri H, Badve S (2011) Biomarkers for breast cancer stem cells: the challenges ahead. Biomark Med 5(5):661\u2013671 (Review)","journal-title":"Biomark Med"},{"issue":"4","key":"3_CR72","doi-asserted-by":"publisher","first-page":"237","DOI":"10.2174\/157488808786734006","volume":"3","author":"JS Moreb","year":"2008","unstructured":"Moreb JS (2008) Aldehyde dehydrogenase as a marker for stem cells. Curr Stem Cell Res Ther 3(4):237\u2013246 (Review)","journal-title":"Curr Stem Cell Res Ther"},{"key":"3_CR73","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.cell.2009.06.034","volume":"138","author":"PB Gupta","year":"2009","unstructured":"Gupta PB, Onder TT, Jiang G, Tao K, Kuperwasser C, Weinberg RA, Lander ES (2009) Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell 138:645\u2013659","journal-title":"Cell"},{"key":"3_CR74","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/j.bbrc.2010.03.138","volume":"394","author":"D Fuchs","year":"2010","unstructured":"Fuchs D, Daniel V, Sadeghi M, Opelz G, Naujokat C (2010) Salinomycin overcomes ABC transporter-mediated multidrug and apoptosis resistance in human leukemia stem cell-like KG-1a cells. Biochem Biophys Res Commun 394:1098\u20131104","journal-title":"Biochem Biophys Res Commun"},{"key":"3_CR75","doi-asserted-by":"publisher","first-page":"7507","DOI":"10.1158\/0008-5472.CAN-09-2994","volume":"69","author":"HA Hirsch","year":"2009","unstructured":"Hirsch HA, Iliopoulos D, Tsichlis PN, Struhl K (2009) Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission. Cancer Res 69:7507\u20137511","journal-title":"Cancer Res"},{"issue":"8","key":"3_CR76","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1093\/carcin\/bgp120","volume":"30","author":"EW LaPensee","year":"2009","unstructured":"LaPensee EW, Schwemberger SJ, LaPensee CR, Bahassi M, Afton SE, Ben-Jonathan N (2009) Prolactin confers resistance against cisplatin in breast cancer cells by activating glutathione-S-transferase. Carcinogenesis 30(8):1298\u20131304","journal-title":"Carcinogenesis"},{"issue":"3","key":"3_CR77","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1124\/jpet.109.160390","volume":"332","author":"Q Li","year":"2010","unstructured":"Li Q, Chow AB, Mattingly RR (2010) Three-dimensional overlay culture models of human breast cancer reveal a critical sensitivity to mitogen-activated protein kinase kinase inhibitors. J Pharmacol Exp Ther 332(3):821\u2013828","journal-title":"J Pharmacol Exp Ther"},{"issue":"Pt 13","key":"3_CR78","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1242\/jcs.079509","volume":"125","author":"BM Baker","year":"2012","unstructured":"Baker BM, Chen CS (2012) Deconstructing the third dimension: how 3D culture microenvironments alter cellular cues. J Cell Sci 125(Pt 13):3015\u20133024","journal-title":"J Cell Sci"},{"issue":"8","key":"3_CR79","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1007\/s00204-013-1080-y","volume":"87","author":"L Schyschka","year":"2013","unstructured":"Schyschka L, S\u00e1nchez JJ, Wang Z, Burkhardt B, M\u00fcller-Vieira U, Zeilinger K, Bachmann A, Nadalin S, Damm G, Nussler AK (2013) Hepatic 3D cultures but not 2D cultures preserve specific transporter activity for acetaminophen-induced hepatotoxicity. Arch Toxicol 87(8):1581\u20131593","journal-title":"Arch Toxicol"},{"issue":"4","key":"3_CR80","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1158\/0008-5472.CAN-09-2314","volume":"70","author":"TH Tran","year":"2010","unstructured":"Tran TH, Utama FE, Lin J, Yang N, Sjolund AB, Ryder A, Johnson KJ, Neilson LM, Liu C, Brill KL, Rosenberg AL, Witkiewicz. AK, Rui H (2010) Prolactin inhibits BCL6 expression in breast cancer through a Stat5a-dependent mechanism. Cancer Res 70(4):1711\u20131721","journal-title":"Cancer Res"},{"issue":"17","key":"3_CR81","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1038\/onc.2013.172","volume":"33","author":"T Sato","year":"2014","unstructured":"Sato T, Tran TH, Peck AR, Girondo MA, Liu C, Goodman CR, Neilson LM, Freydin B, Chervoneva I, Hyslop T, Kovatich AJ, Hooke JA, Shriver CD, Fuchs S, Y., Rui H (2014) Prolactin suppresses a progestin-induced CK5-positive cell population in luminal breast cancer through inhibition of progestin-driven BCL6 expression. Oncogene 33(17):2215\u20132224","journal-title":"Oncogene"},{"key":"3_CR82","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-18736-0","volume-title":"Molecular basis of breast cancer: prevention and treatment","author":"J Russo","year":"2004","unstructured":"Russo J, Russo IH (2004) Molecular basis of breast cancer: prevention and treatment. Springer, Berlin"},{"issue":"15","key":"3_CR83","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1093\/jnci\/82.15.1286","volume":"82","author":"IH Russo","year":"1990","unstructured":"Russo IH, Koszalka M, Russo J (1990) Human chorionic gonadotropin and rat mammary cancer prevention. J Natl Cancer Inst 82(15):1286\u20131289","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"3_CR84","doi-asserted-by":"publisher","first-page":"R12","DOI":"10.1186\/bcr1645","volume":"9","author":"L Rajkumar","year":"2007","unstructured":"Rajkumar L, Kittrell FS, Guzman RC, Brown PH, Nandi S, Medina D (2007) Hormone-induced protection of mammary tumorigenesis in genetically engineered mouse models. Breast Cancer Res 9(1):R12","journal-title":"Breast Cancer Res"},{"issue":"20","key":"3_CR85","doi-asserted-by":"publisher","first-page":"11755","DOI":"10.1073\/pnas.201393798","volume":"98","author":"L Rajkumar","year":"2001","unstructured":"Rajkumar L, Guzman RC, Yang J, Thordarson G, Talamantes F, Nandi S (2001) Short-term exposure to pregnancy levels of estrogen prevents mammary carcinogenesis. Proc Natl Acad Sci U S A 98(20):11755\u201311759","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"3_CR86","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1073\/pnas.96.5.2520","volume":"96","author":"RC Guzman","year":"1999","unstructured":"Guzman RC, Yang J, Rajkumar L, Thordarson G, Chen X, Nandi S (1999) Hormonal prevention of breast cancer: mimicking the protective effect of pregnancy. Proc Natl Acad Sci U S A 96(5):2520\u20132525","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1\u20135","key":"3_CR87","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.jsbmb.2007.05.009","volume":"106","author":"RR Tekmal","year":"2007","unstructured":"Tekmal RR, Nair HB, Perla RP, Kirma N (2007) HER \u20132\/neu x aromatase double transgenic mice model: the effects of aromatase overexpression on mammary tumorigenesis. J Steroid Biochem Mol Biol 106(1\u20135):111\u2013118","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"11","key":"3_CR88","doi-asserted-by":"publisher","first-page":"2744","DOI":"10.1172\/JCI119820","volume":"100","author":"H Wennbo","year":"1997","unstructured":"Wennbo H, Gebre-Medhin M, Gritli-Linde A, Ohlsson C, Isaksson OG, Tornell J (1997) Activation of the prolactin receptor but not the growth hormone receptor is important for induction of mammary tumors in transgenic mice. J Clin Invest 100(11):2744\u20132751","journal-title":"J Clin Invest"},{"issue":"30","key":"3_CR89","doi-asserted-by":"publisher","first-page":"4664","DOI":"10.1038\/sj.onc.1206619","volume":"22","author":"TA Rose-Hellekant","year":"2003","unstructured":"Rose-Hellekant TA, Arendt LM, Schroeder MD, Gilchrist K, Sandgren EP, Schuler LA (2003) Prolactin induces ERalpha-positive and ERalpha-negative mammary cancer in transgenic mice. Oncogene 22(30):4664\u20134674","journal-title":"Oncogene"},{"issue":"7","key":"3_CR90","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1016\/S0021-9258(19)45475-6","volume":"247","author":"P Hwang","year":"1972","unstructured":"Hwang P, Guyda H, Friesen H (1972) Purification of human prolactin. J Biol Chem 247(7):1955\u20131958","journal-title":"J Biol Chem"},{"issue":"3","key":"3_CR91","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1677\/JOE-09-0211","volume":"203","author":"JF Langenheim","year":"2009","unstructured":"Langenheim JF, Chen WY (2009) Improving the pharmacokinetics\/pharmacodynamics of prolactin, GH, and their antagonists by fusion to a synthetic albumin-binding peptide. J Endocrinol 203(3):375\u2013387","journal-title":"J Endocrinol"},{"issue":"2","key":"3_CR92","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.mehy.2007.05.027","volume":"70","author":"G Goodman","year":"2008","unstructured":"Goodman G, Bercovich D (2008) Prolactin does not cause breast cancer and may prevent it or be therapeutic in some conditions. Med Hypotheses 70(2):244\u2013251","journal-title":"Med Hypotheses"},{"issue":"5","key":"3_CR93","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/nrc1070","volume":"3","author":"DW Felsher","year":"2003","unstructured":"Felsher DW (2003) Cancer revoked: oncogenes as therapeutic targets. Nat Rev 3(5):375\u2013380","journal-title":"Nat Rev"}],"container-title":["Advances in Experimental Medicine and Biology","Recent Advances in Prolactin Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-12114-7_3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T12:31:40Z","timestamp":1675254700000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-319-12114-7_3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,4]]},"ISBN":["9783319121130","9783319121147"],"references-count":93,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-12114-7_3","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"type":"print","value":"0065-2598"},{"type":"electronic","value":"2214-8019"}],"subject":[],"published":{"date-parts":[[2014,12,4]]},"assertion":[{"value":"4 December 2014","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}